Tom Williams/Am J Hematol

The Epidemiology of Sickle Cell Disease in Sub-Saharan Africa: Current Knowledge and Gaps to be Filled.Ranque B Tshilolo L Williams TN
Am J Hematol, (2026). 101 Suppl 1:5-16

Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.Power-Hays A Tomlinson GA Tshilolo L Santos B Williams TN Olupot-Olupot P Smart LR Aygun B Lane A Stuber SE Latham T Ware RE
Am J Hematol, (2024). 99:625-632

The significance of spleen size in children with sickle cell anemia.Nardo-Marino A Glenthoj A Brewin JN Petersen J Braunstein TH Kurtzhals JAL Williams TN Rees DC
Am J Hematol, (2022). 97:1520-1528

A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa.Olupot-Olupot P Connon R Kiguli S Opoka RO Alaroker F Uyoga S Nakuya M Okiror W Nteziyaremye J Ssenyondo T Nabawanuka E Kayaga J Williams Mukisa C Amorut D Muhindo R Frost G Walsh K Macharia AW Gibb DM Walker AS George EC Maitland K Williams TN
Am J Hematol, (2022). 97:527-536

Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.McGann PT Williams TN Olupot-Olupot P Tomlinson GA Lane A Luis Reis da Fonseca J Kitenge R Mochamah G Wabwire H Stuber S Howard TA McElhinney K Aygun B Latham T Santos B Tshilolo L Ware RE Reach Investigators
Am J Hematol, (2018). 93:537-545

The clinical epidemiology of sickle cell anemia In Africa.Macharia AW Mochamah G Uyoga S Ndila CM Nyutu G Makale J Tendwa M Nyatichi E Ojal J Shebe M Awuondo KO Mturi N Peshu N Tsofa B Scott JAG Maitland K Williams TN
Am J Hematol, (2018). 93:363-370